ARTICLE | Clinical News
EG-1962: Phase I/II started
November 11, 2013 8:00 AM UTC
Edge began the open-label, dose-escalation, international Phase I/II NEWTON trial to compare a single dose of intraventricular EG-1962 vs. 60 mg oral nimodipine given every 4 hours for 21 days in up t...